Industry Analysis Reports | Health Care | Medical Devices

Thursday, 8 October 2020

News-> Diagnostic Electrocardiograph (ECG) Market Analysis | Size| Share | Report

Market Analysis

The global diagnostic electrocardiograph (ECG) market is likely to touch USD 10,487.24 million at a 6.72% CAGR between 2019- 2025, as per the recent report by Market Research Future (MRFR). Diagnostic electrocardiograph, simply put, is a test that is utilized to detect electrical signals which the heart produces each time it beats. Smart ECG monitors, Holter monitors, event monitors, mobile cardiac telemetry devices, implantable loop recorders, stress ECG devices, and resting ECG devices are the different types of the diagnostic electrocardiograph.

Get Free PDF @https://www.marketresearchfuture.com/sample_request/8787

Various factors are adding to the global diagnostic electrocardiograph market growth. Such factors, according to the new MRFR report, include increasing expenditure by market players in research and development to create novel ECG devices, technological advances in wearable devices and wireless monitoring, and an increase in the rate of lifestyle diseases. Additional factors adding market growth include the developing healthcare infrastructure, increasing geriatric population, and rising cases of cardiovascular diseases.

On the contrary, irregular reimbursement policies, uncertainty in economic circumstances and market saturation, and scarcity of skilled professionals are factors that may limit the diagnostic electrocardiograph market growth over the forecast period

Market Segmentation

The MRFR report offers an inclusive segmental analysis of the global diagnostic electrocardiograph market report based on end user, product type, and lead type.

By product type, the diagnostic electrocardiograph market is segmented into smart ECG monitors, Holter monitors, event monitors, mobile cardiac telemetry devices, implantable loop recorders, stress ECG devices, and resting ECG devices. Of these, the resting ECG devices segment will lead the market over the forecast period for its increasing use in hospitals worldwide.

By lead type, the diagnostic electrocardiograph market is segmented into single-lead ECG devices, 6-lead ECG devices, 3-lead ECG devices, 5-lead ECG devices, and 12-lead ECG devices. Of these, the 3-lead ECG devices segment will dominate the market over the forecast period for its wide applications in various cardiac diagnostic tests.

By end user, the diagnostic electrocardiograph market is ambulatory surgical centers, hospitals and clinics, and others. Of these, the ambulatory surgical centers segment will have a major share in the market over the forecast period for its ample recognition in developing countries.

Regional Analysis

Based on the region, the global diagnostic electrocardiograph market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will have lions share in the market over the forecast period. Surging demand for medical devices coupled with rising cases of cardiovascular diseases like arrhythmia and stroke, are adding to the growth of the market in the region.

The global diagnostic electrocardiograph market in Europe is predicted to hold the second-largest share over the forecast period. Rising acceptance of new diagnostic products and increasing geriatric population are adding to the growth of the market in the region.

The global diagnostic electrocardiograph market in the APAC region is predicted to grow at a fast pace over the forecast period. Rising prevalence of heart diseases like stroke and increasing per capita disposable income are the factors that are adding to the market growth in the region.

The global diagnostic electrocardiograph market in the MEA is predicted to have steady growth over the forecast period. The increasing burden of cardiac diseases and gradually developing healthcare infrastructure are factors that are adding to the market growth in the region.

Key Players

Eminent players profiled in the global diagnostic electrocardiograph market report include VectraCor, Inc. (US), Innomed Medical Inc. (Hungary), Norav Medical (US), Cardioline SpA (Italy), Edan Instruments, Inc. (China), BTL (US), Fukuda Denshi (Japan), BPL Medical Technologies (India), ACS Diagnostics (US), Schiller (Switzerland), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Hillrom Services, Inc. (US), Nihon Kohden Corporation (Japan), Koninklijke Philips N.V. (Netherlands), and General Electric Company (US).

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Industry Trends: Dental Sterilization Market Size | share | Demand by Top Companies

Dental Sterilization Market Research Report by Product (Sterilization Equipment, Surface Disinfectant, Instrument Disinfectant, Washer Disinfector, Lubricant, Cleaning Solutions), End-User (Hospitals, Dental Laboratories) - Global Forecast To 2023

Dental sterilization is a highly crucial part of maintaining the tools and techniques related to dentistry. As per the latest published report by Market Research Future (MRFR), the global dental sterilization market is expected to grow at a CAGR of 6.90% during the forecast period of 2017 to 2023. The market valuation is expected to jump from USD 1.11 billion back in 2017 to USD 1.5 billion by the end of the forecast period.

Get Latest Sample copy @ https://www.marketresearchfuture.com/sample_request/6659

A key driver influencing the demand for dental sterilization is the widespread prevalence of dental related diseases or disorders. Dental caries, one of the most common tooth-related issues, is one of the primary reasons behind the loos of tooth and remains a significant concern across developed economies in the world. Consumption of fast food and sugar-rich food items are acting as the main culprits behind incidences of tooth decay and is likely to continue in the coming years as well, thereby driving the growth of the market over the forecast period.

One of the biggest results out of the growing prevalence of dental diseases have been the rising number of dental care facilities. The growth factor associated with the dentistry field is likely to continue in the near future. This, in turn, helps drive the dental sterilization market towards a period of growth.

Market Segmentation

The global Dental Sterilization Market comprises of the following segments: products and end-users.

By product type, the market includes consumables, instruments, and accessories. Among these, the instruments segment is most likely to maintain its dominance over others in terms of market share contribution during the forecast period.

By end-user, the market divides into dental laboratories and hospitals. The hospitals segment is most likely to remain the largest contributor of the two during the forecast period.

Competitive Analysis

The global dental sterilization market comprises of a number of key players, including Matachana Group, Planmeca Group, Danaher, A-Dec, Hu-Friedy, Scican, Tuttnaue, W&H, BMT Medical Technology, Getinge, Midmark, Dentsply Sirona, Nakanishi, Crosstex, and Premier Dental.

March 12th, 2019, Planmeca became the first-ever dental manufacturer to offer a comprehensive suite of IoT solutions for large clinics as well as clinic chains. The unique device of Planmeca makes it easy to access different sets of data and analyze the same.

March 12th, 2019, Planmeca and Navigate Surgical Technologies, aka NST, a recognized provider of real-time surgical navigation services, announced their collaboration in order to launch innovative solutions for dental implant surgeries. The partnership is promises to offer dental implant surgeons to deliver enhanced and clinical patient outcomes. The tech offers more precise and accurate implant placement.

Regional Analysis

The geographical segmentation of the global dental sterilization market covers the following regions, Europe, Asia Pacific, North America, and the Rest of the World.

North America leads the chart with the highest market share percentage in the global dental sterilization market. This is primarily due to the widespread prevalence of dental-based diseases in the region and ease of availability concerning the use of advanced dental sterilization equipment. Dental caries is one of the most common requirement in dental hygiene, especially in the US, and affects close to 90% of the school-going children. All these factors are poised to make the North American market maintain its topmost standings over the forecast period.

The Asia Pacific region is considered to be an emerging region in the global landscape, however, it plays a major role in the overall development of the market. Herein, fast-paced urbanization in developing countries like India and China has incepted the adoption of Western-like diet system. This has posed to be an increasing problem for the dental health of consumers residing in the Asia Pacific region. Alongside this, the growing number of dental care centers and clinics across these countries is increasingly likely to drive the demand for the global dental sterilization market in the Asia Pacific region during the forecast period.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

News: Custom Antibody Market Size | Trends | Analysis| Demand

Global Custom Antibody Market: By Service (Antibody Development), By Source (Mice, Others), By Research Area (Oncology, Neurobiology), By Type (Monoclonal Antibodies, Polyclonal Antibodies), By End Users (Biotechnology Companies) — Forecast till 2023

Market Highlights:

The Global Custom Antibody Market is expected to register a growth of significant CAGR 9.6% during the forecast period (2018–2023). The custom antibody provides high specificity and selectivity, these are easy to produce as compared to other antibodies and are hence the preferred choice in all types of research studies. Rising geriatric population, growing R&D investment and number of drugs in the pipeline are further anticipated to fuel the market growth. Growth in this segment is mostly driven by the need for high-quality antibodies for research reproducibility and producing high-quality therapeutics.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/7062

Key Players:

Some of the key players in the global custom antibody market are Thermo Fisher Scientific Inc., Genscript, Abcam PLC, Merck Group, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Agilent Technologies, Inc., Biolegend, Inc., Rockland Immunochemicals Inc., Promab Biotechnologies, Inc., Proteogenix, Innovagen Ab.

Segmentation:

The Global Custom Antibody Market has been segmented on the basis of service, source, type, research area and end users.On the basis of service, the market has been classified as antibody development, antibody production & purification, antibody fragmentation & labeling. The antibody development is segmented in to antibody characterization, antigen preparation, immunization & hybridoma production. On the basis of source, the market has been classified as mice, rabbits, human beings and others. On the basis of type, the market has been classified as monoclonal antibodies, polyclonal antibodies, recombinant antibodies, others. On the basis of research area, the market has been classified as oncology, infectious diseases, immunology, neurobiology, stem cells, cardiovascular diseases, other research areas. On the basis of end users, the market has been classified as pharmaceutical & biotechnology companies, hospitals and clinics, academic & research institutes, contract research organizations.

Regional Analysis:

The Americas is projected to lead the custom antibody market in the forecast period. Increasing healthcare awareness, advancement in technology, medical tourism are some other factors that boost the growth of the market. Also, growing investments in the progress of structure-based drug designs, growing focus on developing antibody-based therapeutics, rising research in the fields of genomics field, increasing demand for good quality research tools for data reproducibility and the existence of a huge number of global players in this region.

The European market is expected to hold the second largest market share. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow. According to the Parkinson’s news today, the frequency of Parkinson’s disease in the U.K. is about 1 in 500 people, with a total of about 127,000 people living with the disease. According to Capra Science, a European company specialized in custom antibody production, llama-derived nanobodies might find therapeutic application in Parkinson’s disease.

Asia-Pacific is projected to be the fastest growing region for the global custom antibody in 2018. It is expected to witness profitable growth over the forecast period due to the existence of favorable healthcare schemes drafted by government agencies and growing research activities in the field of mAb-based therapeutics. Awareness programs and quality assurance of diagnostic procedures have added importance in the developing economies of Korea, Taiwan, China, Sri Lanka and India since the last few years.

The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/custom-antibody-market-7062

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

AI in Dug Discovery Market Sees Promising Growth by 2025 According to New Research Report

The AI in drug discovery market is growing continually. Artificial intelligence technology has the potential to revolutionize the pharmaceutical sector and open whole new avenues for technology providers. Resultantly, the adoption of the AI technology to boost efficiency and throughput in clinician workflow is rising steadily. Moreover, the growing applications of AI technology in various drug discovery and development process escalate the market demand to furthered height.

Download Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of AI in drug discovery market 2020 @https://www.marketresearchfuture.com/sample_request/9393

According to Market Research Future (MRFR), the global AI in drug discovery market is poised to create a valuation of USD 2,015.1 MN by 2025, registering a massive 40.8% CAGR throughout the predicted years (2019 – 2025). Recent COVID 19 pandemic is projected to boost the size of the market. AI and machine learning integration in discovery and development applications are increasing to expedite drug development processes.

Also, substantial investments made into AI business are projected to boost the market growth. AI integration minimizes the risk of adverse reactions during trials, reduces the drug discovery timeframe, and, most importantly, reduces drug development costs. Machine learning and other AI tools have a vast potential to make the discovery of new pharmaceuticals faster, cheaper, and more productively. As a result, major pharma companies are increasingly using AI technology for drug discovery.

Moreover, rising numbers of start-ups operating in the AI spectrum drug discovery foster market growth. Simultaneously, increasing numbers of cross-industry partnerships formed to achieve improvements in drug development outcomes drive the growth of the market. On the other hand, high costs associated with AI integration are a major factor estimated to hamper the market growth. Also, the lack of adequate infrastructure in low economic countries obstructs the growth of the market.

AI in Drug Discovery Market – Regional Analysis

North America dominates the global AI in drug discovery market. Market share attributes to the increasing prevalence of chronic diseases and high healthcare expenses. Moreover, the recent COVID 19 pandemic is estimated to increase the size of the regional market. Besides, factors such as the presence of growing numbers of big AI platform developers and a well-developed healthcare sector in the region allow rapid market growth.

Increasing adoption of top AI platforms, including Google AI, Microsoft Azure, and TensorFlow by major pharma companies in drug discovery processes, boost the regional market growth. Moreover, increasing demand for Artificial Intelligence technologies from key pharmaceutical companies such as AbbVie, Genentech, Eli Lilly and Company, and Amgen, among others, drive the growth of the market.

Europe stands second in the global AI in drug discovery market. Market growth is driven by the increasing R&D activities in the pharma sector and the high demand for AI solutions by drug development companies. Top pharma companies in the region form strategic partnerships with international AI service providers to expedite their drug discovery process, which, in turn, boosts the market growth. The UK, Germany, and France are the major growth contributors to the regional market.

Additionally, substantial R&D investments and increasing government funding in the development of AI technology foster regional market growth. Furthermore, the recent COVID 19 epidemic is estimated to increase the size of the regional market. Besides, strategic deals between the UK government and industry players are expected to increase AI research investments. The European AI in the drug discovery market is projected to create a substantial revenue pocket.

The Asia Pacific AI in drug discovery market is estimated to become the fastest-growing market. Factors such as the increasing demand for effective drug discovery solutions and rapidly growing pharmaceutical sectors in the region drive market growth. A number of start-ups in the region are working to integrate AI Drug discovery Market. It is predicted that the adoption of AI technologies in mainstream drug discovery protocols will take place in the future. With their increasing numbers of AI platform companies, countries like India and China contribute significantly to the regional market growth.

AI in Drug Discovery Market - Competitive Analysis

The global AI in drug discovery market appears fiercely competitive & fragmented due to the presence of numerous well-established players. To gain a larger competitive advantage in the market, these players incorporate strategic initiatives such as mergers & acquisitions, collaborations, technology launch, and expansion. Also, AI drug discovery companies make substantial investments to R&D and drive clinical studies.

Major Players:

Players leading the global AI in drug discovery market include Microsoft Corporation, IBM Corporation, Alphabet Inc., Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Bioage, Numerate, Numedii, Inc., Envisagenics, Twoxar, Incorporated, Owkin, Inc., Xtalpi, Inc., Verge Genomics, and Berg LLC, among others.

AI in Drug Discovery Market – Segments

The report is segmented into seven dynamics;

By Product Type : Services and Software.

By Molecule Type: Large and Small Molecules.

By Technology : Machine Learning, Deep Learning, and others.

By Indication : Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and others.

By Application : Target Identification, Candidate Screening, De novo Drug Designing, Drug Optimization & Repurposing, Preclinical Testing, and others.

By End-User : Pharmaceutical & Biotechnology Companies, Research Centers and Academic & Government Institutes, Contract Research Organizations, and others.

By Regions : Americas, Europe, Asia Pacific, and Rest-of-the-World.

Innovation/Industry/Related News:

June 01, 2020 ---- Syntekabio Inc. (South Korea), a bioinformatics venture firm and AI drug Development Company, announced the identification of a respiratory disease drug as a potential COVID19 therapeutics. The crystal structure of SARS-CoV-2’s 3CL protease (Mpro) is the main viral protease that plays a crucial role in viral gene expression and proliferation of the SARS-CoV-2 virus. As soon as this structural information became available, Syntekabio commenced AI screening using its proprietary AI platform DeepMatcherTM and supercomputer. The company screened 3,000 approved drugs and identified potential COVID-19 therapeutics.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Current Trends and Future Demand of Covid19 Impact Connected Healthcare Market Outlook To 2025

Market Synopsis

The global connected medical devices market is presumed to expand at a significant CAGR during the forecast period (2018-2023) owing to the adoption of IT in the healthcare sector, asserts Market Research Future (MRFR). Connected medical devices use wireless or wired connectivity resources in order to collect and monitor patient data. Connected medical devices reduce human error by accurate and uninterrupted data. The market is considered as one of the most lucrative markets and is estimated to generate considerable revenue in the coming years.

Drivers and Constraints Impacting the Market

With the growing prevalence of chronic diseases such as cancer, diabetes, hypertension, and others along with the risk factors associated with it such as asthma, sleep apnea, obesity and others, the global market for connected medical devices is estimated to drive the global market. The increasing patient monitoring systems across the globe, growing adoption of IT in the healthcare sector, and rising awareness regarding connected medical devices are likely to people the market growth during the forecast period. Moreover, technological advancements, quick approval from regulatory authorities for connected medical devices, and research and development activities are anticipated to foster the market. Additionally, key vendors in the consumer wearables market like Fitbit are focusing on maintaining an online presence as it reduces the distribution, setup, and the operational costs. Owing to such advantages, vendors are rapidly penetrating the online platform which is further fostering the market growth.

On the flip side, security concerns, high price of such medical devices, low possibility of adoption in underdeveloped countries, and risk factors associated with data piracy are likely to inhibit the market growth in the coming years. For instance, the US FDA has identified around 300 IoT medical devices that are prone to cyber attack.

Global Connected Medical Devices Market: Segmental Analysis

The global connected medical devices market has been segmented on the basis of device, product, application, end-user, and region.

By mode of product, the global connected medical devices market has been segmented into smart pill dispenser, heart rate monitor, portable GPS pers, pulse oximeter, BP monitor, insulin pump, ECG monitoring devices, glucose monitor, and others. Among these, the device segment is further sub-segmented into wearables and non-wearables.

By mode of application, the global connected medical devices market has been segmented into consultation and diagnosis services, remote monitoring, fitness, treatment services, and wellness services.

By mode of end-users, the global connected medical devices market has been segmented into ambulatory surgical centers, specialty clinics, hospitals, home care settings/monitoring, and others.

Regional Insights

Geographically, the connected medical devices market span across regions namely, Europe, America, Asia Pacific, the Middle East and Africa.

Among all the regions, the American region is anticipated to dominate the global market due to the increasing prevalence of chronic diseases such as diabetes and hypertension, favorable policies from the regulatory authorities and the government, growing awareness regarding connected medical devices, and adoption of advanced technologies by key market players.

Europe is estimated to be the second-largest region due to government funding and support from the healthcare sector. Also, extensive research and development activities and increasing awareness regarding connected medical devices have propelled the market growth in this region.

Asia Pacific is considered to register a moderate growth rate during the assessment period due to increasing prevalence of chronic diseases, adoption of innovative medical technologies, and increasing investment in the healthcare sector in this region.

On the other hand, the Middle East and Africa are presumed to account for the least market share due to underdeveloped healthcare sector, poor medical facilities, and lack of technical knowledge.

Industry News

Sep 26, 2018: Zingbox, the provider of the most widely deployed healthcare Internet of Things analytics platform has recently announced new research demonstrating that hackers are leveraging error messages from connected medical devices. This incorporates X-ray, radiology, and other imaging systems in order to gain valuable insights. These insights are later used to refine the attacks, thus increasing the chance of successful hack.

Competitive Analysis

The major players operating the global market are Philips Healthcare, Johnson & Johnson, Aerotel Medical Systems Ltd., F. Hoffmann-La Roche, Boston Scientific Corporation, iHealth Labs (subsidiary of Andon Health), Medtronic Plc, AgaMatrix Inc., St. Jude Medical Inc. (Abbott), GE Healthcare Inc., Fitbit Inc., McKesson Corporation, Dexcom, OMRON Corporation, and Polar Electro.

Report Details @ https://www.marketresearchfuture.com/reports/connected-healthcare-market

Market Research Analysis:

In recent years, due to the rise in connected healthcare applications has helped in driving the growth of the market. In the coming years, it is expected that the global connected healthcare market will advance with higher growth rate as compared to previous years.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Smart Insulin Pens Market to Grow at a CAGR of 10.4% - Global Growth, Trends, and Forecasts 2019-2023

Smart insulin pens are devices used to deliver the accurate dose of insulin to diabetics at the appropriate time. They have gained traction among diabetics due to its simplistic nature and easy to handle mechanism compared to traditional syringes. The global smart insulin pens market report by Market Research Future (MRFR) contains the pertinent drivers and challenges faced by manufacturers during the period of 2018 to 2023.

Smart Insulin Pens Market Overview

The global smart insulin pens market is expected to exhibit 10.4% CAGR during the forecast period (2018-2023) due to high prevalence of diabetes. Furthermore, the use of these devices for the management of diabetes by the general populace in developing countries can bode well for the market during the forecast period. Awareness of advanced drug delivery methods, need for modern treatments, and the alarming cases of diabetes can bolster the global market demand till 2023.

Get Free Sample Copy With Covid19 Impact@https://www.marketresearchfuture.com/sample_request/6789

The surge in the adoption rate of glucose monitoring devices, awareness of these devices, and integration of glucose measurement devices are other drivers of the market. According to the World Health Organization (WHO), diabetes was accountable for 1.2 million deaths in 2012. This can spark the demand for smart insulin pens for proper management of diabetes. Co-pay assistance and medical reimbursement policies covering the purveying of these devices can ensure the continuous sales.

Unfavorable reimbursement policies, risks associated with insulin pens, and increasing costs of insulin pens are challenges faced by the market.

Smart Insulin Pens Market Segmentation

The global smart insulin pens market has been segmented on the basis of product type, usability, and distribution channel.

On the basis of product type, the market has been segmented into first-generation pens and second-generation pens. The second-generation pens segment has been further divided into Bluetooth-enabled and USB connected.

By usability, the segment has been divided into disposable pens and reusable pens. Reusable insulin pens segment is likely to be the fastest growing segment during the forecast period.

The market, by distribution channel, has been segmented into retail pharmacies, diabetes clinics, online medical stores, and hospital pharmacies.

Smart Insulin Pens Market Regional Analysis

The Middle East & Africa (MEA), Americas, Asia Pacific (APAC), and Europe are regions discussed in the global smart insulin pens market report.

The Americas can be the leading region of the global market till 2023 due to favorable policies by regulatory authorities, adoption of advanced technology, and rising prevalence of diabetes among the general populace. The approval of novel injectable devices by regulatory agencies can drive the global smart insulin pens market growth.

The Europe smart insulin pens market is driven by adoption of advanced drug delivery devices, rising cases of diabetics, and presence of major players. According to the World Diabetes Foundation, more than 59 million have been diagnosed with diabetes, with the number purported to touch 71.1 million by 2040.

Government policies for assisting diabetics and rise in disposable income levels of patients are main drivers of the smart insulin pens market in APAC. Large cases of diabetes recorded in Southeast Asia can drive the regional market growth. As per the International Diabetes Federation, the number of diabetics in the region can touch 156 million by 2045.

Competition Outlook

InjexUK, Lilly USA, LLC, Digital Medics Pty Ltd., Companion Medical, Sanofi-Aventis US LLC, Diamesco Co., Ltd., Smith’s Medical, NIPRO Medical Corporation, Novo Nordisk A/S, Biocorp, Emperra GmbH E-Health Technologies, and others are notable players of the global smart insulin pens market. Manufacturers are launching new iterations of smart insulin pens for recording the proper dosage amounts and reminders of taking insulin shots at the appropriate time. For instance, the InPen by Companion Medical can capture mealtime data and shares it on the respective medical mobile application.

Industry News

Recently, Medtronic and Novo Nordisk have decided to pool in their offerings for sharing the data acquired by their smart insulin pens on a common diabetes management platform.

Read More About report@

https://www.marketresearchfuture.com/reports/smart-insulin-pens-market-6789

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Healthcare Contract Manufacturing Market Gains Momentum With A Striking CAGR

Global Healthcare Contract Manufacturing Market Research Report: Information by Type (Sterile and Non-Sterile), Service Type (Pharmaceutical Contract Manufacturing and Medical Device Contract Manufacturing), Industry (Pharmaceutical Industry, Medical Device Industry and Biopharmaceutical Industry) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023

Overview:

The healthcare contract manufacturing market is benefiting much from the growing demand for medicine supplies which is facing a severe crisis from the pending expiration of a lot of generic drugs. The market relies heavily on the outsourcing of the manufacturing process of drugs to contract manufacturers. From drug development to drug manufacturing, a comprehensive platform this healthcare contract manufacturing sector provides. The from drug development to drug manufacturing market is expecting a growth by 9.86% during the forecast period (2017-2023), claims Market Research Future (MRFR). The report ensures a detailed analysis of the segments and driving factors that can assist the market in growth over the review period.

Among the factors, patent expiration of several drugs can be deemed as one of the chief influencers that can foster the mark

et growth during the forecast period. Emerging economies are demanding for greater percolation as the population boom in those countries have created scope for substantial market expansion. Drug manufacturers are also looking for significant contribution from these companies as number of drugs in the pipeline is getting piled up. Factors such as these are bound to boost the global from drug development to drug manufacturing market.

On the flip side, controlling third parties is quite complex which many manufacturers prefer to avoid. At the same time, clinical trials are becoming more exhaustive and tangled which can deter the healthcare contract manufacturing market from having the expected growth rate over the review period.

Segmentation:

The global healthcare contract manufacturing market can be segmented by type, service type, and industry.

Based on the type, the healthcare contract manufacturing market can be segmented into sterile and non-sterile.

On the basis of the service type, the healthcare contract manufacturing market includes pharmaceutical contract manufacturing services, medical device contract manufacturing services.

Industry-wise segmentation of the healthcare contract manufacturing market includes pharmaceutical, medical device, and biopharmaceutical.

Regional Analysis:

Region-specific analysis of the global healthcare contract manufacturing market includes the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

The Americas is in charge of the global healthcare contract manufacturing market. With rising investment in healthcare, the focus is mainly on improving healthcare infrastructure and upgrading research institutions for better technology and others. Subsequently, manufacturers are now relying more on the advanced instruments they have put in use in their factories and manufacturing capabilities.

Europe assumes the second position in the market and the credit goes to the increased expenditure initiated by the regional governments. The reports published by the Organization for Economic Co-operation and Development (OECD) discloses that Germany spent USD 321 billion in 2014 in the healthcare sector which is a significant marker of the progress the regional market is making at present.

The APAC is the fastest growing market as major regional economies such as China and India are considerably investing to better their healthcare facilities to lure in patients from all over the world as a part of their medical tourism planning.

Competitive Analysis:

Some of the key players in this healthcare contract manufacturing market are Aesica Pharmaceuticals, Boehringer Ingelheim, AbbVie, Grifols International, S.A, Evonik Industries, Lonza Ag, Catalent, Benchmark Electronics, Flex Ltd, Forefront Medical Technologies, Hamilton Company, Sanmina Corporation, Teva Pharmaceutical Industries, Patheon, Mylan, Vetter Pharma International, and others.

In August 2018, Catalent completed their move to acquire Juniper. This would give the former a new and robust European base to function. Catalent, as the parent company of Juniper, would ensure the supply of Crinone marketed by Merck KGaA.

In January 2018, Intermountain Healthcare declared their plan to create a non-profit generic drug company as a direct manufacturer or contract manufacturer in collaboration with Ascension, SSM Health, and Trinity Health.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Healthcare Contract Manufacturing Market Gains Momentum With A Striking CAGR

Industry Analysis Reports | Health Care | Medical Devices | Pharmaceutical

Labels

Thursday, 8 October 2020

News-> Diagnostic Electrocardiograph (ECG) Market Analysis | Size| Share | Report

Industry Trends: Dental Sterilization Market Size | share | Demand by Top Companies

News: Custom Antibody Market Size | Trends | Analysis| Demand

AI in Dug Discovery Market Sees Promising Growth by 2025 According to New Research Report

Current Trends and Future Demand of Covid19 Impact Connected Healthcare Market Outlook To 2025

Smart Insulin Pens Market to Grow at a CAGR of 10.4% - Global Growth, Trends, and Forecasts 2019-2023

Healthcare Contract Manufacturing Market Gains Momentum With A Striking CAGR

Blog Archive

Total Pageviews